文献速递放疗物理与技术姑息放疗与转移瘤

实体恶性肿瘤放疗患者血液学毒性:时间分析、剂量反应及对生存的影响

Hematological toxicity in patients with solid malignant tumors treated with radiation - Temporal analysis, dose response and impact on survival.
PubMed 文献 · Radiother Oncol · 2021-03-01

该队列研究纳入2009-2016年哥本哈根Rigshospitalet接受根治性放疗的实体瘤患者,分析外周血细胞动力学与放疗暴露及生存的关系。结果显示仅淋巴细胞在放疗开始后下降具有临床相关性且持续至一年后,受照体积越大血细胞计数越低,EoRT淋巴细胞减少与放疗后一年内死亡风险升高相关。

要点

  • 放疗开始后仅淋巴细胞下降具有临床相关性,且一年后仍维持低水平。
  • 受照身体体积越大,放疗结束时血细胞计数越低。
  • EoRT淋巴细胞减少患者放疗后一年内死亡风险更高。

核心结论

  • 减少分次数的放疗方案和能降低受照身体体积的放疗技术有望更好地保护患者免疫功能。

研究设计与样本

  • 2009-2016年哥本哈根Rigshospitalet接受根治性放疗且有3D放疗暴露数据的实体瘤患者队列研究。
  • 分析4055例有治疗前和EoRT血小板计数的患者,其中2318例同时有中性粒细胞和淋巴细胞计数。

主要发现

  • 放疗开始后仅淋巴细胞下降具有临床相关性,且放疗后一年仍维持低水平。
  • 受照身体体积越大,EoRT血细胞计数越低。
  • 女性(p < 0.001)、分次数(p = 0.010)、剂量-体积(p < 0.001)及同步化疗尤其是铂类化合物(p < 0.001)与更低的EoRT淋巴细胞计数独立相关。
  • 头颈部癌患者的EoRT淋巴细胞计数最低。
  • 淋巴细胞减少患者放疗后一年内死亡风险高于无淋巴细胞减少患者。

关键数值与推荐

  • 女性与更低EoRT淋巴细胞计数独立相关(p < 0.001)。
  • 分次数与更低EoRT淋巴细胞计数独立相关(p = 0.010)。
  • 剂量-体积与更低EoRT淋巴细胞计数独立相关(p < 0.001)。
  • 同步化疗尤其是铂类化合物与更低EoRT淋巴细胞计数独立相关(p < 0.001)。

临床怎么用

  • 考虑采用较少分次的放疗方案以更好地保护免疫功能。
  • 采用能减少受照身体体积的放疗技术以更好地保护免疫功能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe the kinetics of the peripheral blood components after radiotherapy, to examine radiation exposure vs. End-of-Radiation-Therapy (EoRT) counts and to associate the EoRT lymphocyte count with death and cancer treatment failure. MATERIALS AND METHODS: Cohort study of patients who received curative intent radiotherapy for solid tumor diagnoses from 2009-2016 at Rigshospitalet, Copenhagen and had available 3D radiation exposure data. We illustrated peripheral blood count kinetics within 12 months before and after radiotherapy start and analyzed the impact of the irradiated body volume. We investigated overall survival and cancer treatment failure according to EoRT lymphopenia using Cox regression analyses. RESULTS: We analyzed 4055 patients with both pre-treatment and EoRT platelet counts and 2318 patients who also had neutrophil and lymphocyte counts. Only the lymphocyte decline after radiotherapy start was clinically relevant and remained low one year after radiotherapy. The higher the volume of the body exposed to radiation, the lower the EoRT blood counts. Female gender (p < 0.001), number of fractions (p = 0.010), dose-volume (p < 0.001) and concomitant use of chemotherapy, particularly the platinum compounds (p < 0.001) were independently associated with a lower EoRT lymphocyte count. Patients with head and neck cancer had the lowest EoRT lymphocyte count. Patients with lymphopenia had a higher risk of death in the year after radiotherapy, compared with patients with no lymphopenia. CONCLUSION: Radiation schemes with fewer fractions and radiation techniques allowing reduction of the volume of the body exposed to radiation could be expected to better preserve patients' immune function.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Terrones-Campos C, Ledergerber B, Vogelius IR, et al. Hematological toxicity in patients with solid malignant tumors treated with radiation - Temporal analysis, dose response and impact on survival. Radiother Oncol. 2021. PMID: 33662438. doi:10.1016/j.radonc.2021.02.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。